Literature DB >> 3366779

Discriminatory interaction of purified eukaryotic initiation factors 4F plus 4A with the 5' ends of reovirus messenger RNAs.

T G Lawson1, M H Cladaras, B K Ray, K A Lee, R D Abramson, W C Merrick, R E Thach.   

Abstract

The interaction of several reovirus mRNAs with cap-binding initiation factors has been investigated. Two quantitative experimental techniques have been applied to this question: (a) the rates of reaction of different mRNAs with tobacco acid pyrophosphatase and (b) the extent of cross-linking of different mRNAs to initiation factors in the presence and absence of ATP. The effects of ionic strength on these reactions have also been investigated. Our results demonstrate for the first time that the purified initiation factors interact differentially with purified reovirus mRNAs under competitive conditions and thus confirm earlier interpretations based on kinetic data. Comparison of the data from these studies with the translational behavior of the reovirus mRNAs, both in vitro and in vivo, has also led to specific predictions about features of these mRNAs that determine their competitive efficiencies. 1) Under ordinary ionic conditions, the steric accessibility of the m7G cap moiety of a reovirus mRNA appears to be a major determinant of its translation rate. 2) When the ionic strength is increased to supranormal levels, an additional feature, which may simply be the amount of secondary structure formed by sequences proximal to the cap, can become rate-limiting for several, but not all, of these mRNAs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

3.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.

Authors:  F Rozen; I Edery; K Meerovitch; T E Dever; W C Merrick; N Sonenberg
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

4.  Translational repression in eukaryotes: partial purification and characterization of a repressor of ferritin mRNA translation.

Authors:  W E Walden; S Daniels-McQueen; P H Brown; L Gaffield; D A Russell; D Bielser; L C Bailey; R E Thach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Initiation of translation of the FMR1 mRNA Occurs predominantly through 5'-end-dependent ribosomal scanning.

Authors:  Anna L Ludwig; John W B Hershey; Paul J Hagerman
Journal:  J Mol Biol       Date:  2011-01-12       Impact factor: 5.469

6.  Purification and characterization of mRNA cap-binding protein from Drosophila melanogaster embryos.

Authors:  F G Maroto; J M Sierra
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 7.  Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

Authors:  Jerry Pelletier; Jeremy Graff; Davide Ruggero; Nahum Sonenberg
Journal:  Cancer Res       Date:  2015-01-15       Impact factor: 12.701

8.  Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking.

Authors:  Lisa Lindqvist; Hiroaki Imataka; Jerry Pelletier
Journal:  RNA       Date:  2008-03-26       Impact factor: 4.942

Review 9.  Hippuristanol - A potent steroid inhibitor of eukaryotic initiation factor 4A.

Authors:  Regina Cencic; Jerry Pelletier
Journal:  Translation (Austin)       Date:  2016-01-04

10.  Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.

Authors:  Marianne Koritzinsky; Michaël G Magagnin; Twan van den Beucken; Renaud Seigneuric; Kim Savelkouls; Josée Dostie; Stéphane Pyronnet; Randal J Kaufman; Sherry A Weppler; Jan Willem Voncken; Philippe Lambin; Constantinos Koumenis; Nahum Sonenberg; Bradly G Wouters
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.